CliffBio
small molecule

LIPOFEN

FENOFIBRATE

Loss of exclusivity—loss of exclusivity
CompanyCipher →See this company's full patent-cliff portfolio

Drug detail

Brand nameLIPOFEN
Active ingredientFENOFIBRATE
Strength100MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2006
Marketing statusDISCN

More from Cipher

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LIPOFEN patent cliff — loss of exclusivity — | CliffBio